Saturday 17 October 2026
Export MAIA’s income statement to Excel — free account
MAIA Biotechnology, Inc.
MAIA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 27.8% and free cash flow fell 63.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.10
0.02
−1.79%
Follow MAIA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
4.51 | 5.59 | 1.66 | 1.18 |
+8 more quarters Free account |
Net Debt/EBITDA |
3.32 | 4.95 | 2.01 | 1.16 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.85 | 0.83 | 1.93 | 0.39 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.11) | (0.12) | (0.22) | (0.10) | |
Cash per Share |
0.45 | 0.76 | 0.27 | 0.33 | |
Shareholders Equity per Share |
0.34 | 0.61 | 0.07 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.34 | 0.61 | 0.07 | 0.00 | |
Free Cash Flow |
(6.75) | (5.31) | (7.02) | (3.49) | |
Working Capital |
21.98 | 28.99 | 3.87 | 1.76 | |
Net Current Asset Value |
20.67 | 27.76 | 2.37 | 0.01 | |
| Other line items | |||||
Quick Ratio |
4.41 | 5.44 | 1.48 | 1.10 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.11) | (0.12) | (0.22) | (0.10) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
— | — | — | 0.07 | |
Average Payables |
2.28 | 2.41 | 1.78 | 2.16 | |
Average Assets |
19.64 | 23.59 | 9.93 | 10.51 | |
Average Common Equity |
12.28 | 16.35 | 3.01 | 0.83 |
Columns are period end dates